{
    "clinical_study": {
        "@rank": "16833", 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study\n      measures incorporate an appropriate integration of behavioral and neurobiological indices."
        }, 
        "brief_title": "Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2", 
        "condition": "Cocaine-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Cocaine-Related Disorders"
        }, 
        "detailed_description": {
            "textblock": "Risperidone in low doses is compared with placebo in a 6-week randomized trial.  Subjects\n      also receive supportive counseling.  Outcome measure include rating of behavior, mood, drug\n      abuse, global function, and urine toxicology."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Cocaine abuse or dependence\n\n        Exclusion Criteria:\n\n        Dependence on other drugs.  Major psychiatric illness"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "0", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000310", 
            "org_study_id": "NIDA-09330-2", 
            "secondary_id": "R01-09330-2"
        }, 
        "intervention": {
            "intervention_name": "Risperidone", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Dopamine", 
                "Risperidone", 
                "Serotonin"
            ]
        }, 
        "lastchanged_date": "August 16, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Providence", 
                    "country": "United States", 
                    "state": "Rhode Island", 
                    "zip": "2906"
                }, 
                "name": "Brown University School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Serotonin/Dopamine Antagonism of Cocaine Effect", 
        "overall_official": {
            "affiliation": "Brown University", 
            "last_name": "Lawrence Price, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_outcome": [
            {
                "measure": "Urine toxicology for cocaine"
            }, 
            {
                "measure": "Analog mood scales"
            }, 
            {
                "measure": "POMS"
            }, 
            {
                "measure": "EPS sx"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000310"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "VA Boston Healthcare System", 
                "agency_class": "U.S. Fed"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "January 1996", 
        "study_design": "Allocation: Randomized, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 1996"
    }, 
    "geocoordinates": {
        "Brown University School of Medicine": "41.824 -71.413"
    }
}